🇺🇸 FDA
Patent

US 9242937

Pharmaceutically active disubstituted pyridine derivatives

granted A61KA61K31/4418A61K45/06

Quick answer

US patent 9242937 (Pharmaceutically active disubstituted pyridine derivatives) held by Lead Discovery Center GmbH expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4418, A61K45/06, A61P, A61P15/10